CD8b, Fc Fusion, Avi-Tag Recombinant

Products from BPS Bioscience require a minimum order value above 400€

Encompassing Amino Acids: 22-170

Application: Useful for SDS-PAGE.

Background: CD8 is a co-receptor for the TCR (T cell receptor) in T cells, binding to MHC (major histocompatibility complex) class I proteins. CD8 is a typical marker of cytotoxic T cells and is involved in T cell signaling. CD8 has two isoforms, a and b. CD8b recruits Lck (lymphocyte-specific protein tyrosine kinase) to the TCR-CD3 complex, and Lck phosphorylates multiple proteins involved in activation of cytotoxic T-lymphocytes. It is thus critical for the lysis of cancer cells.

Description: Recombinant human CD8b (cluster of differentiation 8 b), encompassing amino acids 22-170. This construct contains a C-terminus Fc region of human IgG1 followed by an Avi-Tag™. This protein was affinity purified.

Format: Aqueous buffer solution.

Formulation: 8 mM phosphate, pH 7.4, 110 mM NaCl, 2.2 mM KCl, and 20% glycerol

Genbank: NM_172213.5

Host Cell Line: HEK293

Purity: ≥90%

Storage Stability: At least 6 months at -80°C.

Tags: C-terminal Fc, C-terminal Avi-Tag™

Uniprot: P10966

Warnings: Avoid freeze/thaw cycles

Biosafety Level: Not applicable (BSL-1)

• Artikelnummer: BPS101841-1
• Hersteller: BPS Bioscience
• Hersteller Artikelnummer: 101841-1
• Verpackungseinheit: 25 µg
• Mengeneinheit: STK
• Wirt: Human